Baza je ažurirana 30.04.2025. 

zaključno sa NN 70/25

EU 2024/2679
PRESTAO VAŽITI ALI VIDI OVDJE!

NN 6/2022 (14.1.2022.), Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje

   

 

Hrvatski zavod za zdravstveno osiguranje

57

Na osnovi članka 20. stavka 7. Zakona o obveznom zdravstvenom osiguranju (»Narodne novine«, broj 80/13., 137/13. i 98/19.) i članka 26. točke 10. Statuta Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 18/09., 33/10., 08/11., 18/13., 1/14., 83/15. i 108/21.) Upravno vijeće Hrvatskog zavoda za zdravstveno osiguranje na 43. sjednici održanoj 11. siječnja 2022. godine, uz prethodno pribavljeno mišljenje Hrvatske liječničke komore, donijelo je

ODLUKU

O IZMJENAMA I DOPUNAMA ODLUKE O UTVRĐIVANJU OSNOVNE LISTE LIJEKOVA HRVATSKOG ZAVODA ZA ZDRAVSTVENO OSIGURANJE

Članak 1.

U Odluci o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 135/21.), u Osnovnoj listi lijekova iz članka 2. stavka 5. pod šiframa anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije mijenjaju se sljedeći podaci:

»

 

Šifra ATK Oznaka Nezaštićeno ime lijeka DDD i jed. mj. Cijena za DDD Cijena za DDD (s PDV-om) Način primjene Nositelj
odobrenja		 Proizvođač Zaštićeno ime lijeka Oblik, jačina i pakiranje lijeka Cijena jed. oblika Cijena jed. oblika (s PDV-om) Cijena orig. pakiranja Cijena orig. pakiranja (s PDV-om) R/RS
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.
B02BB01 071 DS fibrinogen 5 g 14.690,00 15.424,50 P Jana Pharm d.o.o. Octapharma Pharmazeutika Produktionsges .m.b.H., Octapharma AB Fibryga praš. i otap. za otop. za inj./inf., stak. boč. 1x1 g 2.938,00 3.084,90 2.938,00 3.084,90  
B02BD04 095 DS rekombinantni čimbenik IX (nonakog alfa)NB205       P Pfizer Europe MA EEIG Wyeth Farma S.A. BeneFIX praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. 891,19 935,75 891,19 935,75  
B02BD04 096 DS rekombinantni čimbenik IX (nonakog alfa)NB205       P Pfizer Europe MA EEIG Wyeth Farma S.A. BeneFIX praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. 1.782,38 1.871,50 1.782,38 1.871,50  
B02BD04 097 DS rekombinantni čimbenik IX (nonakog alfa)NB205       P Pfizer Europe MA EEIG Wyeth Farma S.A. BeneFIX praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j. 3.564,76 3.743,00 3.564,76 3.743,00  
B02BD04 098 DS rekombinantni čimbenik IX (nonakog alfa)NB205       P Pfizer Europe MA EEIG Wyeth Farma S.A. BeneFIX praš. i otap. za otop. za inj., boč. stakl. 1x2.000 i.j. 7.129,52 7.486,00 7.129,52 7.486,00  
B05AA01 064 DS ljudski albumin 20%NB502       P Jana Pharm d.o.o. Octapharma Albunorm 20% (non HR) otop. za inf., boč. stakl. 1x100 ml 408,59 429,02 408,59 429,02  
C01CA07 061 DS dobutamin 0,5 g 58,00 60,90 P Panpharma Panpharma GmbH Dobutamin Panpharma konc. za otop. za inf., boč. stakl. 10x250 mg/20 ml 29,00 30,45 290,00 304,50  
D06AX09 461   mupirocin       L GlaxoSmithKline Trading Services Limited Glaxo Operations UK Limited, GlaxoSmithKline Pharmaceuticals S.A. Bactroban mast 1x15 g (20 mg/g) 26,13 27,44 26,13 27,44 R
H05AA02 001 RL teriparatid 20 mcg 54,67 57,40 P PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o., Teva Pharma B.V. Teriparatid Pliva otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml) 1.640,11 1.722,12 1.640,11 1.722,12 RSRH07
J01CR02 171   amoksicilin + klavulanska kiselina 1.5 g 4,04 4,24 O GlaxoSmithKline Trading Services Limited SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production Augmentin tbl. film obl. 14x1 g (875 mg +125 mg) 2,36 2,48 33,00 34,65 RRJ04
J01CR02 273   amoksicilin + klavulanska kiselina 1.5 g 6,01 6,31 O GlaxoSmithKline Trading Services Limited SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production Augmentin susp. 70 ml(400 mg +57 mg)/5 ml 22,45 23,57 22,45 23,57 RRJ04
J01CR05 041 DS piperacilin + tazobaktamNJ101 14 g 216,38 227,20 P Sandoz d.o.o. Sandoz Piperacilin/tazobaktam Sandoz praš. za otop. za inf., boč. 10x(4,0 g+0,5 g)/100ml 61,82 64,91 618,23 649,14  
J01MA12 021 DS levofloksacinNJ105 0,5 g 132,53 139,16 P Sandoz d.o.o. Lek Pharmaceuticals d.d. Levofloksacin Sandoz otop. za inf., vreć. 1x100 ml (5 mg/ml) 132,53 139,16 132,53 139,16  
J05AB06 071 KS ganciklovir 0,5 g 225,94 237,24 P Cheplapharm Arzneimittel GmbH Cheplapharm Arzneimittel GmbH, Prestige Promotion Verkaufsförderung & Werbeservice GmbH Cymevene boč. 1x500 mg/10 ml 225,94 237,24 225,94 237,24  
J05AH01 771 DS zanamivirNJ506 20 mg 22,99 24,14 I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production, Glaxo Operations UK Limited Relenza praš. za inhal. 20x5 mg (5 rotadisk blist. po 4 doze +diskhaler) 5,75 6,03 114,93 120,68  
J05AP54 161 DS elbasvir + grazoprevirNJ711       O Merck Sharp & Dohme B.V. Schering-Plough Labo N.V. Zepatier tbl. film obl. 28x(50 mg+100 mg) 2.488,60 2.613,03 69.680,89 73.164,93  
J05AP54 162 DS elbasvir + grazoprevirNJ711       O Merck Sharp & Dohme B.V. Schering-Plough Labo N.V. Zepatier tbl. film obl. 28x(50 mg+100 mg) 2.488,60 2.613,03 69.680,89 73.164,93  
J06BA01 061   imunoglobulin, ljudskiNJ708       P Jana Pharm d.o.o. Octapharma AB Gammanorm otop. za inj., boč. 1x10 ml (165 mg/ml) 727,77 764,16 727,77 764,16 RSRJ53
J06BD01 051 DS palivizumabNJ605       P                  
J06BD01 084 DS palivizumabNJ605       P AstraZeneca AB AbbVie S.r.l. Synagis otop. za inj., boč. stakl. 1x1 ml (100 mg/mL) 6.252,88 6.565,52 6.252,88 6.565,52  
J07BC01 074 DS cjepivo protiv hepatitisa B       P GlaxoSmithKline Biologicals S.A. GlaxoSmithKline Biologicals S.A. Engerix -B dosis adulta 1x20 mcg/1 ml susp. za inj. u napunj. štrc. 78,87 82,81 78,87 82,81  
J07BC01 075 DS cjepivo protiv hepatitisa B       P GlaxoSmithKline Biologicals S.A. GlaxoSmithKline Biologicals S.A. Engerix -B dosis pediatrica 1x10 mcg/0,5 ml susp. za inj. u napunj. štrc. 48,00 50,40 48,00 50,40  
J07BD52 061 PR cjepivo protiv morbila-parotitisa-rubele (MO-PA-RU)       P GlaxoSmithKline Biologicals S.A. GlaxoSmithKline Biologicals S.A. Priorix cjepivo kombinirano, liof., boč. 1x1 doza +štrc. napunj. s 0,5 ml vode za injekcije+2 igle sa zaštitom 66,32 69,64 66,32 69,64  
J07CA06 071 PR cjepivo protiv difterije, tetanusa-DT, pertusisa-(acelularno), poliomijelitisa-IPV (inaktivirano), adsorbirano i Haemophilus influenzae tip b (konjugirano)NJ707       P GlaxoSmithKline Biologicals S.A. GlaxoSmithKline Biologicals S.A. Infanrix-IPV+Hib štrc. stakl. 1x0,5 ml +1 stakl.boč. s praškom +2 igle sa zaštitom, susp. 141,29 148,35 141,29 148,35  
L01EA01 101 DS imatinibNL115 400 mg 218,28 229,19 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o. Plivatinib tbl. film obl. 60x100 mg 54,57 57,30 3.274,20 3.437,91  
L01EA01 102 DS imatinibNL115 400 mg 209,51 219,99 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o. Plivatinib tbl. film obl. 30x400 mg 209,51 219,99 6.285,30 6.599,57  
L01EA01 121 DS imatinibNL458 400 mg 171,23 179,80 O Sandoz d.o.o. Lek Pharmaceuticals d.d., Salutas Pharma GmbH Imatinib Sandoz tbl. film obl. 60x100 mg 42,81 44,95 2.568,51 2.696,94  
L01EA01 122 DS imatinibNL458 400 mg 169,86 178,35 O Sandoz d.o.o. Lek Pharmaceuticals d.d., Salutas Pharma GmbH Imatinib Sandoz tbl. film obl. 30x400 mg 169,86 178,35 5.095,71 5.350,50  
L01EA01 135 DS imatinib NL115 400 mg 218,28 229,19 O KRKA-FARMA d.o.o. KRKA-FARMA d.o.o., Krka d.d. Meaxin tbl. film obl. 60x100 mg 54,57 57,30 3.274,20 3.437,91  
L01EA01 136 DS imatinib NL115 400 mg 222,05 233,16 O KRKA-FARMA d.o.o. KRKA-FARMA d.o.o., Krka d.d. Meaxin tbl. film obl. 90x100 mg 55,51 58,29 4.996,20 5.246,01  
L01EA01 137 DS imatinibNL115 400 mg 209,51 219,99 O KRKA-FARMA d.o.o. KRKA-FARMA d.o.o., Krka d.d. Meaxin tbl. film obl. 30x400 mg 209,51 219,99 6.285,30 6.599,57  
L01EA01 138 DS imatinib NL115 400 mg 204,52 214,75 O KRKA-FARMA d.o.o. KRKA-FARMA d.o.o., Krka d.d. Meaxin tbl. film obl. 60x400 mg 204,52 214,75 12.271,20 12.884,76  
L01EA01 141 DS imatinibNL115 400 mg 162,67 170,81 O Alkaloid-INT d.o.o. Alkaloid - INT d.o.o. Imatinib Alkaloid-INT tbl. film obl. 60x100 mg 40,67 42,70 2.440,08 2.562,08  
L01EA01 142 DS imatinibNL115 400 mg 161,36 169,43 O Alkaloid-INT d.o.o. Alkaloid - INT d.o.o. Imatinib Alkaloid-INT tbl. film obl. 30x400 mg 161,36 169,43 4.840,92 5.082,97  
L01EA01 161 DS imatinibNL115 400 mg 218,28 229,19 O Zentiva k.s. Remedica Ltd., Pharmadox Healthcare Ltd. Imakrebin tbl. film obl. 60x100 mg 54,57 57,30 3.274,20 3.437,91  
L01EA01 162 DS imatinibNL115 400 mg 209,51 219,99 O Zentiva k.s. Remedica Ltd., Pharmadox Healthcare Ltd. Imakrebin tbl. film obl. 30x400 mg 209,51 219,99 6.285,30 6.599,57  
L01EA01 173 DS imatinibNL115 400 mg 209,51 219,99 O Novartis Europharm Limited Irska Novartis Pharma Glivec tbl. film obl. 30x400 mg 209,51 219,99 6.285,30 6.599,57  
L01EA01 193 DS imatinibNL115 400 mg 190,26 199,77 O Accord Healthcare S.L.U. Accord Healthcare Limited Imatinib Accord tbl. film obl. 60x100 mg 47,57 49,94 2.853,90 2.996,60  
L01EA01 194 DS imatinibNL115 400 mg 188,73 198,17 O Accord Healthcare S.L.U. Accord Healthcare Limited Imatinib Accord tbl. film obl. 30x400 mg 188,73 198,17 5.661,90 5.945,00  
L01EA02 161 DS dasatinibNL119 100 mg 1.002,50 1.052,62 O Bristol-Myers Squibb Pharma EEIG Bristol-Myers Squibb Sprycel tbl. film obl. 60x20 mg 200,50 210,53 12.030,00 12.631,50  
L01EA02 163 DS dasatinibNL119 100 mg 603,42 633,59 O Bristol-Myers Squibb Pharma EEIG Bristol-Myers Squibb Sprycel tbl. film obl. 30x100 mg 603,42 633,59 18.102,60 19.007,73  
L01EA02 171 DS dasatinibNL119 100 mg 701,75 736,84 O Zentiva k.s. Synthon Hispania S.L., Synthon BV Dasatinib Zentiva tbl. film obl. 60x20 mg 140,35 147,37 8.421,00 8.842,05  
L01EA02 172 DS dasatinibNL119 100 mg 422,39 443,51 O Zentiva k.s. Synthon Hispania S.L., Synthon BV Dasatinib Zentiva tbl. film obl. 30x100 mg 422,39 443,51 12.671,82 13.305,41  
L01EA03 171 DS nilotinibNL121 600 mg 655,85 688,64 O Novartis Europharm Limited Irska Novartis Pharma Stein AG Tasigna caps. tvrda 112x200 mg 218,62 229,55 24.485,07 25.709,32  
L01EA04 161 DS bosutinibNL119 400 mg 704,91 740,16 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Bosulif tbl. film obl. 28x100 mg 176,23 185,04 4.934,40 5.181,12  
L01EA04 162 DS bosutinibNL119 400 mg 706,20 741,51 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Bosulif tbl. film obl. 28x500 mg 882,75 926,89 24.717,00 25.952,85  
L01EA05 161 DS ponatinibNL526 45 mg 2.093,90 2.198,60 O Incyte Biosciences Distribution B.V. Incyte Biosciences Distribution B.V. Iclusig tbl. film obl. 60x15 mg 697,97 732,87 41.878,00 43.971,90  
L01EA05 162 DS ponatinibNL526 45 mg 1.350,29 1.417,80 O Incyte Biosciences Distribution B.V. Incyte Biosciences Distribution B.V. Iclusig tbl. film obl. 30x45 mg 1.350,29 1.417,80 40.508,60 42.534,03  
L01EB01 101 DS gefitinibNL419 250 mg 248,34 260,76 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o. Gefitinib Pliva tbl. film obl. 30x250 mg 248,34 260,76 7.450,20 7.822,71  
L01EB01 141 DS gefitinibNL419 250 mg 235,92 247,72 O Alkaloid-INT d.o.o. Alkaloid - INT d.o.o. Phrompo tbl. film obl. 30x250 mg 235,92 247,72 7.077,69 7.431,57  
L01EB01 171 DS gefitinibNL419 250 mg 306,60 321,93 O ALPHA-MEDICAL d.o.o. Synthon Hispania S.L., Synthon BV Gefitinib Alpha-Medical tbl. film obl. 30x250 mg 306,60 321,93 9.198,00 9.657,90  
L01EB01 181 DS gefitinibNL419 250 mg 306,60 321,93 O Sandoz d.o.o. Remedica Ltd., Lek Pharmaceuticals d.d. Gefitinib Sandoz tbl. film obl. 30x250 mg 306,60 321,93 9.198,00 9.657,90  
L01EB01 191 DS gefitinibNL419 250 mg 275,94 289,74 O Zentiva k.s. Pharmadox Healthcare Limited, S.C Labormed - Pharma SA Gefitinib Zentiva tbl. film obl. 30x250 mg 275,94 289,74 8.278,20 8.692,11  
L01EB02 161 DS erlotinibNL116 150 mg 243,05 255,20 O Roche Registration GmbH Roche Tarceva tbl. film obl. 30x150 mg 243,05 255,20 7.291,46 7.656,03  
L01EB02 162 DS erlotinibNL116 150 mg 243,05 255,20 O Zentiva k.s. Remedica Ltd. Varlota tbl. film obl. 30x150 mg 243,05 255,20 7.291,46 7.656,03  
L01EB02 163 DS erlotinibNL116 150 mg 243,05 255,20 O Remedica Ltd. Remedica Ltd. Erlotinib Remedica tbl. film obl. 30x150 mg 243,05 255,20 7.291,46 7.656,03  
L01EB02 164 DS erlotinibNL116 150 mg 243,05 255,20 O PharmaS d.o.o. Remedica Ltd. Erlotinib PharmaS tbl. film obl. 30x150 mg 243,05 255,20 7.291,46 7.656,03  
L01EB02 165 DS erlotinibNL116 150 mg 243,05 255,20 O ACTAVIS GROUP PTC ehf. S.C. Sindan-Pharma S.R.L. Erlotinib Actavis tbl. film obl. 30x150 mg 243,05 255,20 7.291,46 7.656,03  
L01EB02 166 DS erlotinibNL116 150 mg 218,74 229,68 O Sandoz d.o.o. Lek Pharmaceuticals d.d., Remedica Ltd. Erlotinib Sandoz tbl. film obl. 30x150 mg 218,74 229,68 6.562,31 6.890,43  
L01EB02 167 DS erlotinibNL116 150 mg 196,87 206,71 O Mylan S.A.S Remedica Ltd. Erlotinib Mylan tbl. film obl. 30x150 mg 196,87 206,71 5.906,08 6.201,38  
L01EB02 168 DS erlotinibNL116 150 mg 187,03 196,38 O KRKA-FARMA d.o.o. Krka d.d. Erlotinib Krka tbl. film obl. 30x150 mg 187,03 196,38 5.610,78 5.891,32  
L01EB03 161 DS afatinibNL419 40 mg 1.032,76 1.084,40 O Boehringer Ingelheim International GmbH Boehringer Ingelheim Giotrif tbl. film obl. 28x20 mg 516,38 542,20 14.458,64 15.181,57  
L01EB03 162 DS afatinibNL419 40 mg 688,51 722,93 O Boehringer Ingelheim International GmbH Boehringer Ingelheim Giotrif tbl. film obl. 28x30 mg 516,38 542,20 14.458,64 15.181,57  
L01EB03 163 DS afatinibNL419 40 mg 516,38 542,20 O Boehringer Ingelheim International GmbH Boehringer Ingelheim Giotrif tbl. film obl. 28x40 mg 516,38 542,20 14.458,64 15.181,57  
L01EB04 161 KS osimertinibNL473 80 mg 3.037,70 3.189,59 O AstraZeneca AB AstraZeneca AB Tagrisso tbl. film obl. 28x40 mg 1.518,85 1.594,79 42.527,80 44.654,19  
L01EB04 162 KS osimertinibNL473 80 mg 1.518,85 1.594,79 O AstraZeneca AB AstraZeneca AB Tagrisso tbl. film obl. 28x80 mg 1.518,85 1.594,79 42.527,80 44.654,19  
L01EC01 061 KS vemurafenibNL422 1920 mg 1.716,24 1.802,05 O Roche Registration GmbH Roche Pharma AG Zelboraf tbl. film obl. 56x240 mg 214,53 225,26 12.013,68 12.614,36  
L01EC02 162 KS dabrafenibNL422 300 mg 1.576,26 1.655,07 O Novartis Europharm Limited Irska Glaxo Wellcome S.A. Tafinlar caps. tvrda 120x50 mg 262,71 275,85 31.525,20 33.101,46  
L01EC02 163 KS dabrafenibNL422 300 mg 1.584,39 1.663,61 O Novartis Europharm Limited Irska Glaxo Wellcome S.A. Tafinlar caps. tvrda 120x75 mg 396,10 415,90 47.531,60 49.908,18  
L01ED01 161 DS krizotinibNL444 500 mg 1.366,22 1.434,53 O Pfizer Europe MA EEIG Pfizer Xalkori caps. tvrda 60x200 mg 546,49 573,81 32.789,29 34.428,75  
L01ED01 162 DS krizotinibNL444 500 mg 1.092,98 1.147,63 O Pfizer Europe MA EEIG Pfizer Xalkori caps. tvrda 60x250 mg 546,49 573,81 32.789,29 34.428,75  
L01ED03 161 DS alektinibNL474 1200 mg 1.418,75 1.489,68 O Roche Registration GmbH Roche Pharma AG Alecensa caps. tvrda 224x150 mg 177,34 186,21 39.724,91 41.711,16  
L01ED04 071 DS brigatinibNL501 180 mg 1.377,96 1.446,86 O Takeda Pharma A/S Takeda Austria GmbH, Penn Pharmaceutical Services Limited Alunbrig tbl. film obl. 28x30 mg 229,66 241,14 6.430,48 6.752,00  
L01ED04 072 DS brigatinibNL501 180 mg 1.356,29 1.424,11 O Takeda Pharma A/S Takeda Austria GmbH, Penn Pharmaceutical Services Limited Alunbrig tbl. film obl. 28x90 mg 678,15 712,05 18.988,11 19.937,52  
L01ED04 073 DS brigatinibNL501 180 mg 1.128,97 1.185,42 O Takeda Pharma A/S Takeda Austria GmbH, Penn Pharmaceutical Services Limited Alunbrig tbl. film obl. 28x180 mg 1.128,97 1.185,42 31.611,16 33.191,72  
L01ED04 074 DS brigatinibNL501 180 mg 1.290,25 1.354,76 O Takeda Pharma A/S Takeda Austria GmbH, Penn Pharmaceutical Services Limited Alunbrig tbl. film obl. (7x90 mg+21x180 mg) 1.128,97 1.185,42 31.611,16 33.191,72  
L01ED05 161 DS lorlatinibNL511 100 mg 1.422,46 1.493,58 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Lorviqua tbl. film obl. 90x25 mg 355,62 373,40 32.005,35 33.605,62  
L01ED05 162 DS lorlatinibNL511 100 mg 1.423,27 1.494,43 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Lorviqua tbl. film obl. 120x25 mg 355,82 373,61 42.698,09 44.832,99  
L01ED05 163 DS lorlatinibNL511 100 mg 1.066,85 1.120,19 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Lorviqua tbl. film obl. 30x100 mg 1.066,85 1.120,19 32.005,35 33.605,62  
L01EE01 161 KS trametinibNL422 2 mg 1.108,47 1.163,89 O Novartis Europharm Limited Irska Glaxo Wellcome, S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH Mekinist tbl. film obl. 30x0,5 mg 277,12 290,97 8.313,50 8.729,18  
L01EE01 162 KS trametinibNL422 2 mg 1.099,61 1.154,59 O Novartis Europharm Limited Irska Glaxo Wellcome, S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH Mekinist tbl. film obl. 30x2 mg 1.099,61 1.154,59 32.988,30 34.637,72  
L01EE02 161 KS kobimetinibNL422 45 mg 1.362,64 1.430,77 O Roche Registration GmbH Roche Pharma AG Cotellic tbl. film obl. 63x20 mg 605,62 635,90 38.153,85 40.061,54  
L01EF01 161 DS palbociklibNL478 94 mg 1.482,60 1.556,73 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance caps. tvrda 21x75 mg 1.182,92 1.242,07 24.841,39 26.083,46  
L01EF01 162 DS palbociklibNL478 94 mg 1.111,95 1.167,55 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance caps. tvrda 21x100 mg 1.182,92 1.242,07 24.841,39 26.083,46  
L01EF01 163 DS palbociklibNL478 94 mg 889,56 934,04 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance caps. tvrda 21x125 mg 1.182,92 1.242,07 24.841,39 26.083,46  
L01EF01 164 DS palbociklibNL478 94 mg 1.211,49 1.272,07 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance tbl. film obl. 21x75 mg 966,62 1.014,95 20.298,95 21.313,90  
L01EF01 165 DS palbociklibNL478 94 mg 908,62 954,05 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance tbl. film obl. 21x100 mg 966,62 1.014,95 20.298,95 21.313,90  
L01EF01 166 DS palbociklibNL478 94 mg 726,90 763,24 O Pfizer Europe MA EEIG Pfizer Manufacturing Deutschland GmbH Ibrance tbl. film obl. 21x125 mg 966,62 1.014,95 20.298,95 21.313,90  
L01EF02 161 DS ribociklibNL479 450 mg 805,95 846,25 O Novartis Europharm Limited Irska Novartis Pharma GmbH Kisqali tbl. film obl. 63x200 mg 358,20 376,11 22.566,60 23.694,93  
L01EF03 171 DS abemaciklibNL498 300 mg 1.988,31 2.087,73 O Eli Lilly Nederland B.V. Lilly S.A. Verzenios tbl. film obl. 28x50 mg 331,39 347,95 9.278,78 9.742,72  
L01EF03 172 DS abemaciklibNL498 300 mg 994,16 1.043,86 O Eli Lilly Nederland B.V. Lilly S.A. Verzenios tbl. film obl. 28x100 mg 331,39 347,95 9.278,78 9.742,72  
L01EF03 173 DS abemaciklibNL498 300 mg 662,77 695,91 O Eli Lilly Nederland B.V. Lilly S.A. Verzenios tbl. film obl. 28x150 mg 331,39 347,95 9.278,78 9.742,72  
L01EG01 071 DS temsirolimusNL122 3.57 mg 764,60 802,83 P Pfizer Europe MA EEIG Wyeth Torisel konc. i otap. za inf. boč. stakl. 1x30 mg/1,2 ml+boč. stakl. 1x2,2 ml 6.425,25 6.746,51 6.425,25 6.746,51  
L01EG01 081 DS temsirolimusNL122 3.57 mg 535,22 561,99 P Accord Healthcare Polska Sp. z o.o. Accord Healthcare Polska Sp. z o.o., Accord Healthcare B.V. Temsirolimus Accord konc. i otap. za otop. za inf. boč. stakl. 30 mg, 1 boč. s konc. i 1 boč. s otap. 4.497,68 4.722,56 4.497,68 4.722,56  
L01EG02 101 DS everolimusNL420 10 mg 568,49 596,92 O PLIVA HRVATSKA d.o.o. Teva Gyogyszergyar Zrt. Everolimus Pliva tbl. 30x5 mg 284,25 298,46 8.527,39 8.953,76  
L01EG02 102 DS everolimusNL420 10 mg 388,32 407,73 O PLIVA HRVATSKA d.o.o. Teva Gyogyszergyar Zrt. Everolimus Pliva tbl. 30x10 mg 388,32 407,73 11.649,47 12.231,94  
L01EG02 131 DS everolimusNL420 10 mg 511,64 537,23 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 30x2,5 mg 127,91 134,31 3.837,33 4.029,20  
L01EG02 132 DS everolimusNL420 10 mg 460,48 483,50 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 90x2,5 mg 115,12 120,88 10.360,78 10.878,82  
L01EG02 133 DS everolimusNL420 10 mg 511,64 537,23 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 30x5 mg 255,82 268,61 7.674,65 8.058,38  
L01EG02 134 DS everolimusNL420 10 mg 460,48 483,50 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 90x5 mg 230,24 241,75 20.721,56 21.757,64  
L01EG02 135 DS everolimusNL420 10 mg 349,48 366,96 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 30x10 mg 349,48 366,96 10.484,52 11.008,75  
L01EG02 136 DS everolimusNL420 10 mg 314,54 330,26 O KRKA-FARMA d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Krka tbl. 90x10 mg 314,54 330,26 28.308,20 29.723,61  
L01EG02 171 DS everolimusNL420 10 mg 568,49 596,92 O Alvogen Pharma Trading Europe EOOD Genepharm S.A., Pharmadox Healthcare Limited Everolimus Alvogen tbl. 30x5 mg 284,25 298,46 8.527,39 8.953,76  
L01EG02 172 DS everolimusNL420 10 mg 388,32 407,73 O Alvogen Pharma Trading Europe EOOD Genepharm S.A., Pharmadox Healthcare Limited Everolimus Alvogen tbl. 30x10 mg 388,32 407,73 11.649,47 12.231,94  
L01EG02 181 DS everolimusNL420 10 mg 568,49 596,92 O STADA d.o.o. Stada Arzneimittel Everolimus STADA tbl. 30x5 mg 284,25 298,46 8.527,39 8.953,76  
L01EG02 182 DS everolimusNL420 10 mg 388,32 407,73 O STADA d.o.o. Stada Arzneimittel Everolimus STADA tbl. 30x10 mg 388,32 407,73 11.649,47 12.231,94  
L01EG02 183 DS everolimusNL420 10 mg 568,49 596,92 O Mylan S.A.S Synthon Hispania S.L., Synthon BV Everolimus Mylan tbl. 30x5 mg 284,25 298,46 8.527,39 8.953,76  
L01EG02 184 DS everolimusNL420 10 mg 388,32 407,73 O Mylan S.A.S Synthon Hispania S.L., Synthon BV Everolimus Mylan tbl. 30x10 mg 388,32 407,73 11.649,47 12.231,94  
L01EG02 185 DS everolimusNL420 10 mg 568,49 596,92 O ALPHA-MEDICAL d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Alpha-Medical tbl. 30x5 mg 284,25 298,46 8.527,39 8.953,76  
L01EG02 186 DS everolimusNL420 10 mg 388,32 407,73 O ALPHA-MEDICAL d.o.o. Synthon Hispania S.L., Synthon BV Everolimus Alpha-Medical tbl. 30x10 mg 388,32 407,73 11.649,47 12.231,94  
L01EH01 161 DS lapatinibNL120 1250 mg 581,80 610,89 O Novartis Europharm Limited Irska Glaxo Operations UK Ltd; Glaxo Wellcome S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH Tyverb tbl. film obl. 70x250 mg 116,36 122,18 8.145,20 8.552,46  
L01EJ01 161 DS ruksolitinibNL453 30 mg 1.518,20 1.594,11 O Novartis Europharm Limited Irska Novartis Pharma GmbH Jakavi tbl. 56x5 mg 253,03 265,69 14.169,87 14.878,36  
L01EJ01 162 DS ruksolitinibNL453 30 mg 994,82 1.044,56 O Novartis Europharm Limited Irska Novartis Pharma GmbH Jakavi tbl. 56x15 mg 497,41 522,28 27.855,00 29.247,75  
L01EJ01 163 DS ruksolitinibNL453 30 mg 746,12 783,42 O Novartis Europharm Limited Irska Novartis Pharma GmbH Jakavi tbl. 56x20 mg 497,41 522,28 27.855,00 29.247,75  
L01EK01 161 DS aksitinibNL430 10 mg 799,20 839,16 O Pfizer Europe MA EEIG Pfizer Inlyta tbl. film obl. 56x1 mg 79,92 83,92 4.475,52 4.699,30  
L01EK01 162 DS aksitinibNL430 10 mg 799,20 839,16 O Pfizer Europe MA EEIG Pfizer Inlyta tbl. film obl. 56x5 mg 399,60 419,58 22.377,60 23.496,48  
L01EL01 161 DS ibrutinibNL502 420 mg 1.350,39 1.417,91 O Janssen-Cilag International N.V. Janssen Imbruvica caps. tvrda 90x140 mg 450,13 472,64 40.511,70 42.537,29  
L01EL01 162 DS ibrutinibNL471 420 mg 1.349,80 1.417,29 O Janssen-Cilag International N.V. Janssen Imbruvica caps. tvrda 120x140 mg 449,93 472,43 53.992,00 56.691,60  
L01EL01 163 DS ibrutinibNL527 420 mg 1.349,80 1.417,29 O Janssen-Cilag International N.V. Janssen-Cilag SpA Imbruvica tbl. film obl. 28x140 mg 449,93 472,43 12.598,13 13.228,04  
L01EL01 164 DS ibrutinibNL527 420 mg 1.349,80 1.417,29 O Janssen-Cilag International N.V. Janssen-Cilag SpA Imbruvica tbl. film obl. 28x280 mg 899,87 944,86 25.196,27 26.456,08  
L01EL01 165 DS ibrutinibNL527 420 mg 1.349,80 1.417,29 O Janssen-Cilag International N.V. Janssen-Cilag SpA Imbruvica tbl. film obl. 28x420 mg 1.349,80 1.417,29 37.794,40 39.684,12  
L01EL01 166 DS ibrutinibNL471 420 mg 1.349,80 1.417,29 O Janssen-Cilag International N.V. Janssen-Cilag SpA Imbruvica tbl. film obl. 28x560 mg 1.799,73 1.889,72 50.392,53 52.912,16  
L01EM01 161 DS idelalisibNL454 300 mg 1.371,48 1.440,05 O Gilead Sciences Ireland UC Gilead Sciences Ireland UC Zydelig tbl. film obl. 60x100 mg 457,16 480,02 27.429,60 28.801,08  
L01EM01 162 DS idelalisibNL454 300 mg 914,32 960,04 O Gilead Sciences Ireland UC Gilead Sciences Ireland UC Zydelig tbl. film obl. 60x150 mg 457,16 480,02 27.429,60 28.801,08  
L01EX01 101 DS sunitinibNL117 33 mg 557,72 585,61 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. Sunitinib Pliva caps. tvrda 28x12,5 mg 211,26 221,82 5.915,22 6.210,98  
L01EX01 102 DS sunitinibNL117 33 mg 555,17 582,93 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. Sunitinib Pliva caps. tvrda 28x25 mg 420,59 441,62 11.776,40 12.365,22  
L01EX01 103 DS sunitinibNL117 33 mg 552,92 580,57 O PLIVA HRVATSKA d.o.o. Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. Sunitinib Pliva caps. tvrda 28x50 mg 837,76 879,65 23.457,41 24.630,28  
L01EX01 131 DS sunitinibNL117 33 mg 557,73 585,61 O KRKA-FARMA d.o.o. Krka d.d, Krka - farma d.o.o. Sunitinib Krka caps. tvrda 30x12,5 mg 211,26 221,82 6.337,80 6.654,69  
L01EX01 132 DS sunitinibNL117 33 mg 555,18 582,94 O KRKA-FARMA d.o.o. Krka d.d, Krka - farma d.o.o. Sunitinib Krka caps. tvrda 30x25 mg 420,59 441,62 12.617,70 13.248,59  
L01EX01 133 DS sunitinibNL117 33 mg 552,92 580,57 O KRKA-FARMA d.o.o. Krka d.d, Krka - farma d.o.o. Sunitinib Krka caps. tvrda 30x50 mg 837,76 879,65 25.132,80 26.389,44  
L01EX01 164 DS sunitinibNL117 33 mg 796,74 836,58 O Pfizer Europe MA EEIG Pfizer Sutent caps. tvrda 28x12,5 mg 301,80 316,89 8.450,31 8.872,83  
L01EX01 165 DS sunitinibNL117 33 mg 793,10 832,76 O Pfizer Europe MA EEIG Pfizer Sutent caps. tvrda 28x25 mg 600,84 630,88 16.823,43 17.664,60  
L01EX01 166 DS sunitinibNL117 33 mg 789,89 829,39 O Pfizer Europe MA EEIG Pfizer Sutent caps. tvrda 28x50 mg 1.196,81 1.256,65 33.510,59 35.186,12  
L01EX01 171 DS sunitinibNL117 33 mg 529,83 556,33 O STADA d.o.o. STADA Arzneimittel AG, STADA Arzneimittel GmbH Sunitinib Stada caps. tvrda 28x12,5 mg 200,70 210,73 5.619,46 5.900,43  
L01EX01 172 DS sunitinibNL117 33 mg 527,41 553,79 O STADA d.o.o. STADA Arzneimittel AG, STADA Arzneimittel GmbH Sunitinib Stada caps. tvrda 28x25 mg 399,56 419,53 11.187,58 11.746,96  
L01EX01 173 DS sunitinibNL117 33 mg 525,28 551,54 O STADA d.o.o. STADA Arzneimittel AG, STADA Arzneimittel GmbH Sunitinib Stada caps. tvrda 28x50 mg 795,88 835,67 22.284,54 23.398,77  
L01EX01 174 DS sunitinibNL117 33 mg 529,83 556,33 O Accord Healthcare S.L.U. Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Accord caps. tvrda 30x12,5 mg 200,70 210,73 6.020,85 6.321,89  
L01EX01 175 DS sunitinibNL117 33 mg 527,41 553,79 O Accord Healthcare S.L.U. Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Accord caps. tvrda 30x25 mg 399,56 419,53 11.986,69 12.586,02  
L01EX01 176 DS sunitinibNL117 33 mg 525,28 551,54 O Accord Healthcare S.L.U. Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Accord caps. tvrda 30x50 mg 795,88 835,67 23.876,29 25.070,10  
L01EX01 177 DS sunitinibNL117 33 mg 529,83 556,33 O Sandoz d.o.o. Remedica Ltd., Lek Pharmaceuticals d.d. Sunitinib Sandoz caps. tvrda 28x12,5 mg 200,70 210,73 5.619,46 5.900,43  
L01EX01 178 DS sunitinibNL117 33 mg 527,41 553,79 O Sandoz d.o.o. Remedica Ltd., Lek Pharmaceuticals d.d. Sunitinib Sandoz caps. tvrda 28x25 mg 399,56 419,53 11.187,58 11.746,96  
L01EX01 179 DS sunitinibNL117 33 mg 525,28 551,54 O Sandoz d.o.o. Remedica Ltd., Lek Pharmaceuticals d.d. Sunitinib Sandoz caps. tvrda 28x50 mg 795,88 835,67 22.284,54 23.398,77  
L01EX01 181 DS sunitinibNL117 33 mg 503,34 528,51 O Mylan Ireland Limited Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Mylan caps. tvrda 28x12,5 mg 190,66 200,19 5.338,49 5.605,41  
L01EX01 182 DS sunitinibNL117 33 mg 501,04 526,10 O Mylan Ireland Limited Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Mylan caps. tvrda 28x25 mg 379,58 398,56 10.628,20 11.159,61  
L01EX01 183 DS sunitinibNL117 33 mg 499,01 523,97 O Mylan Ireland Limited Remedica Ltd., Pharmacare Premium Ltd. Sunitinib Mylan caps. tvrda 28x50 mg 756,08 793,89 21.170,31 22.228,83  
L01EX01 184 DS sunitinibNL117 33 mg 478,18 502,09 O ALPHA-MEDICAL d.o.o. Synthon s.r.o., Synthon BV Sunitinib Alpha-Medical caps. tvrda 28x12,5 mg 181,13 190,18 5.071,57 5.325,15  
L01EX01 185 DS sunitinibNL117 33 mg 475,99 499,79 O ALPHA-MEDICAL d.o.o. Synthon s.r.o., Synthon BV Sunitinib Alpha-Medical caps. tvrda 28x25 mg 360,60 378,63 10.096,79 10.601,63  
L01EX01 186 DS sunitinibNL117 33 mg 474,06 497,77 O ALPHA-MEDICAL d.o.o. Synthon s.r.o., Synthon BV Sunitinib Alpha-Medical caps. tvrda 28x50 mg 718,28 754,19 20.111,79 21.117,38  
L01EX01 187 DS sunitinibNL117 33 mg 478,18 502,09 O Zentiva k.s. Remedica Ltd., Pharmacare Premium Ltd. Zesuva caps. tvrda 28x12,5 mg 181,13 190,18 5.071,57 5.325,15  
L01EX01 188 DS sunitinibNL117 33 mg 475,99 499,79 O Zentiva k.s. Remedica Ltd., Pharmacare Premium Ltd. Zesuva caps. tvrda 28x25 mg 360,60 378,63 10.096,79 10.601,63  
L01EX01 189 DS sunitinibNL117 33 mg 474,06 497,77 O Zentiva k.s. Remedica Ltd., Pharmacare Premium Ltd. Zesuva caps. tvrda 28x50 mg 718,28 754,19 20.111,79 21.117,38  
L01EX02 171 KLDS sorafenibNL118 800 mg 586,06 615,36 O Bayer AG Bayer HealthCare AG Nexavar tbl. film obl. 112x200 mg 146,51 153,84 16.409,65 17.230,13  
L01EX02 172 KLDS sorafenibNL517 800 mg 586,06 615,36 O Mylan Ireland Limited Remedica Ltd. Sorafenib Mylan tbl. film obl. 112x200 mg 146,51 153,84 16.409,65 17.230,13  
L01EX02 173 KLDS sorafenibNL517 800 mg 586,06 615,36 O STADA d.o.o. STADA Arzneimittel AG, STADA Arzneimittel GmbH Sorafenib Stada tbl. film obl. 112x200 mg 146,51 153,84 16.409,65 17.230,13  
L01EX02 174 KLDS sorafenibNL517 800 mg 586,06 615,36 O Teva B.V. Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. Sorafenib Teva tbl. film obl. 112x200 mg 146,51 153,84 16.409,65 17.230,13  
L01EX02 175 KLDS sorafenibNL517 800 mg 556,76 584,59 O Sandoz d.o.o. Remedica Ltd., Lek Pharmaceuticals d.d. Sorafenib Sandoz tbl. film obl. 112x200 mg 139,19 146,15 15.589,17 16.368,63  
L01EX02 176 KLDS sorafenibNL517 800 mg 556,76 584,59 O Zentiva k.s. Remedica Ltd. Fenesa tbl. film obl. 112x200 mg 139,19 146,15 15.589,17 16.368,63  
L01EX02 177 KLDS sorafenibNL517 800 mg 528,92 555,36 O Pharmascience International Limited Remedica Ltd., PharOS MT Ltd. Sorafenib Pharmascience tbl. film obl. 112x200 mg 132,23 138,84 14.809,71 15.550,20  
L01EX03 161 KLDS pazopanibNL421 800 mg 699,71 734,69 O Novartis Europharm Limited Irska Glaxo Operations UK Ltd, Glaxo Wellcome, S.A. Votrient tbl. film obl. 30x200 mg 174,93 183,67 5.247,80 5.510,19  
L01EX03 162 KLDS pazopanibNL421 800 mg 688,81 723,25 O Novartis Europharm Limited Irska Glaxo Operations UK Ltd, Glaxo Wellcome, S.A. Votrient tbl. film obl. 30x400 mg 344,40 361,62 10.332,10 10.848,71  
L01EX05 161 DS regorafenibNL470 120 mg 603,92 634,12 O Bayer AG Bayer AG Stivarga tbl. film obl. 84x40 mg 201,31 211,37 16.909,76 17.755,25  
L01EX09 161 KS nintedanibNL455 380 mg 800,98 841,03 O Boehringer Ingelheim International GmbH Boehringer Ingelheim Pharma GmbH Ofev caps. meka 60x100 mg 210,78 221,32 12.647,00 13.279,35  
L01EX09 162 KS nintedanibNL455 380 mg 738,81 775,75 O Boehringer Ingelheim International GmbH Boehringer Ingelheim Pharma GmbH Ofev caps. meka 60x150 mg 291,64 306,22 17.498,20 18.373,11  
L01EX09 171 DS nintedanibNL472 380 mg 538,88 565,82 O Boehringer Ingelheim International GmbH Boerhinger Ingelheim Vargatef caps. meka 120x100 mg 141,81 148,90 17.017,24 17.868,10  
L01EX09 172 DS nintedanibNL472 380 mg 718,51 754,43 O Boehringer Ingelheim International GmbH Boerhinger Ingelheim Vargatef caps. meka 60x150 mg 283,62 297,80 17.017,24 17.868,10  
L01EX10 171 KL midostaurinNL489 100 mg 3.549,21 3.726,67 O Novartis Europharm Limited Irska Novartis Pharma GmbH Rydapt caps. meka 112x25 mg 887,30 931,67 99.377,85 104.346,74  
L01FA01 061 DS rituksimabNL518       P Roche Registration GmbH Roche Mabthera boč. 2x100 mg/10 ml 1.520,08 1.596,08 3.040,16 3.192,17  
L01FA01 062 DS rituksimabNL518       P Roche Registration GmbH Roche Mabthera boč. 1x500 mg/50 ml 7.464,09 7.837,29 7.464,09 7.837,29  
L01FA01 063 DS rituksimabNL429       P Roche Registration GmbH Roche Mabthera otop. za supkut. inj., boč. 1x1400 mg 10.504,25 11.029,46 10.504,25 11.029,46  
L01FA01 071 DS rituksimabNL518       P Celltrion Healthcare Hungary Kft. Biotec Services International Ltd. Truxima konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml 7.464,09 7.837,29 7.464,09 7.837,29  
L01FA01 072 DS rituksimabNL518       P Celltrion Healthcare Hungary Kft. Biotec Services International Ltd. Truxima konc. za otop. za inf., boč. stakl. 2x100 mg/10 ml 1.520,08 1.596,08 3.040,16 3.192,17  
L01FA01 081 DS rituksimabNL518       P Sandoz GmbH Sandoz GmbH Rixathon konc. za otop. za inf., boč. stakl. 2x100 mg/10 ml 1.368,07 1.436,47 2.736,14 2.872,95  
L01FA01 082 DS rituksimabNL518       P Sandoz GmbH Sandoz GmbH Rixathon konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml 6.717,68 7.053,56 6.717,68 7.053,56  
L01FA01 083 DS rituksimabNL111       P Pfizer Europe MA EEIG Pfizer Manufacturing Belgium NV Ruxience konc. za otop. za inf., boč. stakl. 1x100 mg/10 ml 1.299,67 1.364,65 1.299,67 1.364,65  
L01FA01 084 DS rituksimabNL111       P Pfizer Europe MA EEIG Pfizer Manufacturing Belgium NV Ruxience konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml 6.381,80 6.700,89 6.381,80 6.700,89  
L01FA03 061 DS obinutuzumabNL451       P Roche Registration GmbH Roche Pharma AG Gazyvaro konc. za otop. za inf., boč. stakl. 1x1000 mg/40 ml 24.898,97 26.143,92 24.898,97 26.143,92  
L01FC01 071 KS daratumumabNL492       P Janssen-Cilag International N.V. Janssen Biologics B.V Darzalex konc. za otop. za inf., boč. stakl. 1x100 mg/5 ml 3.221,44 3.382,51 3.221,44 3.382,51  
L01FC01 072 KS daratumumabNL492       P Janssen-Cilag International N.V. Janssen Biologics B.V Darzalex konc. za otop. za inf., boč. stakl. 1x400 mg/20 ml 12.649,05 13.281,50 12.649,05 13.281,50  
L01FC01 073 KS daratumumabNL492       P Janssen-Cilag International N.V. Janssen Biologics B.V Darzalex otop. za supkut. inj., boč. 1x1800 mg/15 ml 38.207,30 40.117,67 38.207,30 40.117,67  
L01FD01 061 DS trastuzumab NL112       P Roche Registration GmbH Roche Herceptin boč. 1x150 mg 2.935,41 3.082,18 2.935,41 3.082,18  
L01FD01 062 DS trastuzumab NL487       P Roche Registration GmbH Roche Herceptin otop. za supkut. inj., boč. 1x600 mg/5 ml 8.806,23 9.246,54 8.806,23 9.246,54  
L01FD01 071 DS trastuzumab NL112       P Celltrion Healthcare Hungary Kft. Biotec Services International Ltd Herzuma boč. 1x150 mg 2.935,41 3.082,18 2.935,41 3.082,18  
L01FD01 072 DS trastuzumab NL112       P Mylan S.A.S McDermott Laboratories Limited T/A Mylan Dublin Biologics Ogivri boč. 1x150 mg 2.788,64 2.928,07 2.788,64 2.928,07  
L01FD01 081 DS trastuzumab NL112       P Amgen Europe B.V. Amgen Europe B.V. Kanjinti boč. 1x150 mg 2.935,41 3.082,18 2.935,41 3.082,18  
L01FD01 082 DS trastuzumab NL112       P Amgen Europe B.V. Amgen Europe B.V. Kanjinti boč. 1x420 mg 8.219,15 8.630,11 8.219,15 8.630,11  
L01FD01 083 DS trastuzumab NL112       P Pfizer Europe MA EEIG Wyeth Pharmaceuticals, Pfizer Manufacturing Belgium NV Trazimera boč. 1x150 mg 2.935,41 3.082,18 2.935,41 3.082,18  
L01FD01 084 DS trastuzumab NL112       P Accord Healthcare S.L.U. Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o. Zercepac boč. 1x150 mg 2.649,21 2.781,67 2.649,21 2.781,67  
L01FD01 085 DS trastuzumab NL112       P Accord Healthcare S.L.U. Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o. Zercepac boč. 1x60 mg 1.006,70 1.057,04 1.006,70 1.057,04  
L01FD01 086 DS trastuzumab NL112       P Accord Healthcare S.L.U. Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o. Zercepac boč. 1x420 mg 7.311,82 7.677,41 7.311,82 7.677,41  
L01FD02 061 DS pertuzumabNL443       P Roche Registration GmbH Roche Pharma AG Perjeta konc. za otop. za inf., boč. stakl. 1x420 mg 19.988,62 20.988,05 19.988,62 20.988,05  
L01FD03 061 DS trastuzumab emtanzinNL450       P Roche Registration GmbH Roche Pharma AG Kadcyla praš. za konc. za otop. za inf., boč. stakl. 1x100 mg 12.739,00 13.375,95 12.739,00 13.375,95  
L01FD03 062 DS trastuzumab emtanzinNL450       P Roche Registration GmbH Roche Pharma AG Kadcyla praš. za konc. za otop. za inf., boč. stakl. 1x160 mg 20.376,00 21.394,80 20.376,00 21.394,80  
L01FE01 061 DS cetuksimabNL113       P Merck Europe B.V. Merck Healthcare KGaA Erbitux otop. za inf., boč. 1x20 ml (5 mg/ml) 1.389,84 1.459,33 1.389,84 1.459,33  
L01FE02 061 DS panitumumabNL431       P Amgen Europe B.V. Amgen Europe B.V. Vectibix konc. za otop. za inf., boč. 1x5 ml (20 mg/ml) 2.763,47 2.901,64 2.763,47 2.901,64  
L01FF01 061 KS nivolumabNL467       P Bristol-Myers Squibb Pharma EEIG Bristol - Myers Squibb S.r.l. Opdivo konc. za otop. za inf., boč. stakl. 1x4 ml (10 mg/ml) 3.953,05 4.150,70 3.953,05 4.150,70  
L01FF01 062 KS nivolumabNL467       P Bristol-Myers Squibb Pharma EEIG Bristol - Myers Squibb S.r.l. Opdivo konc. za otop. za inf., boč. stakl. 1x10 ml (10 mg/ml) 9.759,60 10.247,58 9.759,60 10.247,58  
L01FF01 063 KS nivolumabNL467       P Bristol-Myers Squibb Pharma EEIG Bristol - Myers Squibb S.r.l. Opdivo konc. za otop. za inf., boč. stakl. 1x24 ml (10 mg/ml) 23.472,25 24.645,86 23.472,25 24.645,86  
L01FF02 062 KS pembrolizumabNL452       P Merck Sharp & Dohme B.V. Schering - Plough Labo NV Keytruda konc. za otop. za inf., boč. stakl. 1x100 mg/4 ml (25 mg/ml) 22.683,16 23.817,32 22.683,16 23.817,32  
L01FF03 061 KS durvalumabNL515       P AstraZeneca AB AstraZeneca Pharmaceuticals LP Imfinzi konc. za otop. za inf., boč. stakl. 1x120 mg/2,4 ml (50mg/ml) 4.927,37 5.173,74 4.927,37 5.173,74  
L01FF03 062 KS durvalumabNL515       P AstraZeneca AB AstraZeneca Pharmaceuticals LP Imfinzi konc. za otop. za inf., boč. stakl. 1x500 mg/10 ml (50mg/ml) 20.224,46 21.235,68 20.224,46 21.235,68  
L01FF04 061 KL avelumabNL519       P Merck Europe B.V. Merck Serono S.p.A. Bavencio konc. za otop. za inf. 10 ml, boč. stakl. 1x20 mg/ml 6.947,17 7.294,53 6.947,17 7.294,53  
L01FF05 071 KS atezolizumabNL529       P Roche Registration GmbH Roche Pharma AG Tecentriq konc. otop. za inf., boč. 1x1200 mg/20 ml 30.555,70 32.083,49 30.555,70 32.083,49  
L01FF05 072 KS atezolizumabNL529       P Roche Registration GmbH Roche Pharma AG Tecentriq konc. otop. za inf., boč. 1x840 mg/14 ml 21.388,99 22.458,44 21.388,99 22.458,44  
L01FG01 061 DS bevacizumab NL128       P Roche Registration GmbH Roche Avastin konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) 1.954,83 2.052,57 1.954,83 2.052,57  
L01FG01 062 DS bevacizumabNL128       P Roche Registration GmbH Roche Avastin konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) 7.274,05 7.637,75 7.274,05 7.637,75  
L01FG01 071 DS bevacizumab NL128       P Amgen Technology (Ireland) UC Amgen Technology (Ireland) UC Mvasi konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) 1.835,66 1.927,44 1.835,66 1.927,44  
L01FG01 072 DS bevacizumab NL128       P Amgen Technology (Ireland) UC Amgen Technology (Ireland) UC Mvasi konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) 7.015,60 7.366,38 7.015,60 7.366,38  
L01FG01 073 DS bevacizumab NL128       P Mabxience Research S.L. GH Genhelix S.A. Alymsys konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) 1.743,88 1.831,07 1.743,88 1.831,07  
L01FG01 074 DS bevacizumab NL128       P Mabxience Research S.L. GH Genhelix S.A. Alymsys konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) 6.664,82 6.998,06 6.664,82 6.998,06  
L01FG01 075 DS bevacizumab NL128       P STADA Arzneimittel AG GH GENHELIX S.A. Oyavas konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) 1.743,88 1.831,07 1.743,88 1.831,07  
L01FG01 076 DS bevacizumab NL128       P STADA Arzneimittel AG GH GENHELIX S.A. Oyavas konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) 6.664,82 6.998,06 6.664,82 6.998,06  
L01FG01 077 DS bevacizumab NL128       P Mylan IRE Healthcare Ltd McDermott Laboratories Limited t/a Mylan Dublin Biologics, Mylan Germany GmbH Abevmy konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) 1.656,69 1.739,52 1.656,69 1.739,52  
L01FG01 078 DS bevacizumab NL128       P Mylan IRE Healthcare Ltd McDermott Laboratories Limited t/a Mylan Dublin Biologics, Mylan Germany GmbH Abevmy konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) 6.331,58 6.648,16 6.331,58 6.648,16  
L01FG02 061 KS ramucirumabNL469       P Eli Lilly Nederland B.V. Lilly, S.A. Cyramza konc. za otop. za inf., boč. stakl. 2x10 ml (10 mg/ml) 3.822,69 4.013,82 7.645,38 8.027,65  
L01FX02 061 KS gemtuzumab ozogamicinNL525       P Pfizer Europe MA EEIG Pfizer Ireland Pharmaceuticals Mylotarg praš. za konc. za otop. za inf., boč. stakl. 1x5 mg 57.699,86 60.584,85 57.699,86 60.584,85  
L01FX04 061 KS ipilimumabNL523       P Bristol-Myers Squibb Pharma EEIG CATALENT ANAGNI S.R.L., Swords Laboratories T/A Bristol-Myers Squibb Cruiserath Biologics Yervoy konc. za otop. za inf., boč. stakl. 1x10 ml (5 mg/ml) 26.558,64 27.886,57 26.558,64 27.886,57  
L01FX05 061 DS brentuksimab vedotinNL442       P Takeda Pharma A/S Takeda Italia S.p.A. Adcetris praš. za konc. za otop. za inf., boč. stakl. 1x50 mg 22.143,91 23.251,11 22.143,91 23.251,11  
L01FX06 061 KL dinutuksimab betaNL508       P EUSA Pharma (Netherlands) B.V. Millmount Healthcare Ltd Qarziba konc. za otop. za inf., boč. stakl. 1x20 mg (4,5 mg/ml) 69.464,16 72.937,37 69.464,16 72.937,37  
L01EM03 171 DS alpelisibNL531 300 mg 1.045,34 1.097,61 O Novartis Europharm Limited Irska Novartis Pharma GmbH Piqray tbl. film obl. 28x50 mg + 28x200 mg 435,56 457,34 24.391,36 25.610,93  
L01EM03 172 DS alpelisibNL531 300 mg 871,12 914,68 O Novartis Europharm Limited Irska Novartis Pharma GmbH Piqray tbl. film obl. 56x150 mg 435,56 457,34 24.391,36 25.610,93  
L01EM03 173 DS alpelisibNL531 300 mg 1.306,68 1.372,01 O Novartis Europharm Limited Irska Novartis Pharma GmbH Piqray tbl. film obl. 28x200 mg 871,12 914,68 24.391,36 25.610,93  
L02BB06 161 DS darolutamidNL514 120 mg 80,64 84,67 O Bayer AG Orion Corporation, Orion Pharma Nubeqa tbl. film obl. 112x300 mg 201,59 211,67 22.578,08 23.706,98  
L04AA43 061 KL ravulizumab NL524 58.9 mg 6.372,84 6.691,48 P Alexion Europe SAS Alexion Pharma International Operations Unlimited Company Ultomiris konc. za otop. za inf., boč. stakl. 1x300 mg (30 ml, 10 mg/ml) 32.459,30 34.082,27 32.459,30 34.082,27  
L04AA44 161   upadacitinibNL512 15 mg 180,25 189,27 O AbbVie Deutschland GmbH & Co. KG AbbVie S.r.l. Rinvoq tbl. s prod. oslob. 28x15 mg 180,25 189,27 5.047,08 5.299,43 RSRL107
N02CC01 162   sumatriptan 50 mg 9,36 9,82 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Imigran tbl. 2x50 mg 9,36 9,82 18,71 19,65 RSRN03
N03AX09 175   lamotrigin 0,3 g 4,31 4,52 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Lamictal tbl. 56x25 mg 0,36 0,38 20,11 21,12 RSRN22
N03AX09 176   lamotrigin 0,3 g 6,70 7,03 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Lamictal tbl. 56x50 mg 1,12 1,17 62,50 65,63 RSRN22
N03AX09 177   lamotrigin 0,3 g 5,85 6,14 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Lamictal tbl. 56x100 mg 1,95 2,05 109,20 114,66 RSRN22
N03AX09 180   lamotrigin 0,3 g 55,20 57,96 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Lamictal tbl. za žvak./oral. susp. 60x5 mg 0,92 0,97 55,20 57,96 RSRN22
N04BC04 176   ropinirol 6 mg 9,66 10,14 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc Requip Modutab tbl. s prod. oslob. 28x2 mg 2,29 2,40 64,12 67,33 R
N04BC04 177   ropinirol 6 mg 9,15 9,60 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc Requip Modutab tbl. s prod. oslob. 28x4 mg 4,48 4,70 125,31 131,58 R
N04BC04 178   ropinirol 6 mg 8,09 8,50 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc Requip Modutab tbl. s prod. oslob. 28x8 mg 8,51 8,94 238,28 250,19 R
N06AB05 111   paroksetin 20 mg 0,64 0,68 O GlaxoSmithKline Trading Services Limited GlaxoSmithKline Pharmaceuticals S.A. Seroxat tbl. 30x20 mg 0,64 0,68 19,29 20,25 R
N06AX27 761 DS esketaminNN507 8 mg 492,35 516,97 N Janssen-Cilag International N.V. Janssen Pharmaceutica NV Spravato sprej za nos, 1x28 mg 1.723,22 1.809,38 1.723,22 1.809,38  
R03AC12 763   salmeterol 0,1 mg 4,60 4,83 I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production Serevent inhaler stlač. inhalat, susp., 120x25 mcg 1,15 1,21 138,00 144,90 R
R03AK06 361   salmeterol + flutikazon       I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production, Glaxo Operations UK Ltd. Seretide 100 Diskus praš. za inhal. 60x(50+100 mcg)/doza 1,86 1,96 111,72 117,31 RRR02
R03AK06 362   salmeterol + flutikazon       I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production, Glaxo Operations UK Ltd. Seretide 250 Diskus praš. za inhal. 60x(50+250 mcg)/doza 2,42 2,54 144,90 152,15 RRR02
R03AK06 363   salmeterol + flutikazon       I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production, Glaxo Operations UK Ltd. Seretide 500 Diskus praš. za inhal. 60x(50+500 mcg)/doza 3,18 3,34 190,68 200,21 RRR03
R03BA05 773   flutikazon 0,6 mg 6,12 6,43 I GlaxoSmithKline Trading Services Limited Glaxo Wellcome Production, GlaxoWellcome S.A. Flixotide inhaler stlač. inhalat, susp. 120x50 mcg 0,51 0,54 61,20 64,26 RRR07

 

 

 

 

«.

Dodaju se nove šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

 

Šifra ATK Oznaka Nezaštićeno ime lijeka DDD i jed. mj. Cijena za DDD Cijena za DDD (s PDV-om) Način primjene Nositelj
odobrenja		 Proizvođač Zaštićeno
ime lijeka		 Oblik, jačina i pakiranje lijeka Cijena jed. oblika Cijena jed. oblika (s PDV-om) Cijena orig. pakiranja Cijena orig. pakiranja (s PDV-om) R/RS
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.
B05AA01 964 DS ljudski albumin 20%NB502       P Jana Pharm d.o.o. Octapharma Albunorm 20% (HR) otop. za inf., boč. stakl. 1x100 ml 326,87 343,21 326,87 343,21  
J01DD01 061 DS cefotaksimNJ101 4 g 87,44 91,81 P Apta Medica International d.o.o. ACS Dobfar S.p.A. Cefotaksim AptaPharma praš. za otop. za inj/inf., boč. 10x1 g 21,86 22,95 218,60 229,53  
J01DD01 062 DS cefotaksimNJ101 4 g 87,28 91,65 P Apta Medica International d.o.o. ACS Dobfar S.p.A. Cefotaksim AptaPharma praš. za otop. za inj/inf., boč. 10x2 g 43,64 45,82 436,41 458,23  
J01DH02 085 DS meropenemNJ101 3 g 250,26 262,77 P Ligula Pharma d.o.o. Venus Pharma GmbH Meropenem Ligula Pharma praš. za otop. za inj. ili inf., boč. 10x500 mg 41,71 43,80 417,10 437,96  
J01DH02 086 DS meropenemNJ101 3 g 228,42 239,84 P Ligula Pharma d.o.o. Venus Pharma GmbH Meropenem Ligula Pharma praš. za otop. za inj. ili inf., boč. 10x1000 mg 76,14 79,95 761,40 799,47  
J01XA01 083 DS vankomicinNJ101 2 g 91,20 95,76 P Apta Medica International d.o.o. Laboratorio Reig Jofre S.A. Vankomicin AptaPharma praš. za otop. za inf., boč. 10x500 mg 22,80 23,94 228,00 239,40  
J01XA01 084 DS vankomicinNJ101 2 g 84,66 88,90 P Apta Medica International d.o.o. Laboratorio Reig Jofre S.A. Vankomicin AptaPharma praš. za otop. za inf., boč. 10x1000 mg 42,33 44,45 423,32 444,49  
L01BA04 045 DS pemetreksedNL102       P Accord Healthcare S.L.U. Accord Healthcare Limited, Wessling Hungary Kft Pemetrexed Accord konc. za otop. za inf., boč. 1x1000 mg 5.828,35 6.119,77 5.828,35 6.119,77  
L01XK04 161 DS talazoparibNL530       O Pfizer Europe MA EEIG Excella GmbH & Co. KG Talzenna caps. 30x0,25 mg 450,87 473,41 13.526,10 14.202,41  
L01XK04 162 DS talazoparibNL530       O Pfizer Europe MA EEIG Excella GmbH & Co. KG Talzenna caps. 30x1 mg 1.341,08 1.408,13 40.232,40 42.244,02  
V06DX03 492   namirnice za enteralnu primjenu       O G-M Pharma Zagreb d.o.o. Nutricia Nutridrink Compact Protein boca 4x125 ml 16,25 17,06 65,00 68,25 RSVS04a

 

 

«.

Brišu se šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

 

Šifra ATK Oznaka Nezaštićeno ime lijeka DDD i jed. mj. Cijena za DDD Cijena za DDD (s PDV-om) Način primjene Nositelj odobrenja Proizvođač Zaštićeno ime lijeka Oblik, jačina i pakiranje lijeka Cijena jed. oblika Cijena jed. oblika (s PDV-om) Cijena orig. pakiranja Cijena orig. pakiranja (s PDV-om) R/RS
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.
A04AA05 081 DS palonosetronNA402 0,25 mg 238,59 250,52 P Alvogen Pharma Trading Europe EOOD Haupt Pharma Wolfrathausen GmbH Palonozetron Alvogen otop. za inj., boč. 1x250 mcg/5 ml 238,59 250,52 238,59 250,52  
C07AB07 143   bisoprolol 10 mg 0,83 0,87 O Jadran - Galenski Laboratorij d.d. JGL d.d. Lybrol tbl. 30x3,75 mg 0,31 0,33 9,32 9,79 R
C08CA05 131   nifedipin srednje dugodjelujući 30 mg 0,71 0,74 O KRKA-FARMA d.o.o. Krka d.d. Cordipin R tbl. 30x20 mg 0,47 0,49 14,11 14,82 R
J05AP01 171 DS ribavirin 1 g 81,48 85,56 O Roche d.o.o. Roche Copegus tbl. film obl. 42x200 mg 16,30 17,11 684,46 718,68  
L01BA01 005 DS metotreksat       P Zentiva k.s. Pliva Hrvatska d.o.o. Metotreksat Zentiva otop. za inj., boč. stakl. 1x5 mg/2 ml (2,5 mg/1 ml) 12,79 13,43 12,79 13,43  
L01EA01 172 DS imatinibNL115       O Novartis Europharm Limited Irska Novartis Pharma Glivec tbl. film obl. 60x100 mg 54,57 57,30 3.274,20 3.437,91  
L02AB01 171   megestrol-acetat 0,16 g 8,11 8,51 O PharmaSwiss Česka republika s.r.o Polfarmex S.A. Megoxi susp. za oral. primj. 1x240 ml (40 mg/ml) 486,50 510,83 486,50 510,83 RSRL22
N05AX08 113   risperidon 5 mg 4,92 5,16 O Belupo d.d. Belupo Prospera tbl. film obl. 60x3 mg 2,95 3,10 177,00 185,85 RSRN06
N05AX08 114   risperidon 5 mg 6,57 6,90 O Belupo d.d. Belupo Prospera tbl. film obl. 60x4 mg 5,26 5,52 315,40 331,17 RSRN06

 

 

 

«.

Dodaje se nova indikacija pod oznakom: »NL530« koja glasi:

»NL530: Monoterapija za liječenje odraslih bolesnika sa zametnim mutacijama gena BRCA1 i BRCA2 koji boluju od lokalno uznapredovalog ili metastatskog trostruko-negativnog raka dojke. Bolesnici su prethodno trebali biti liječeni antraciklinom i/ili taksanom u (neo)adjuvantnom, lokalno uznapredovalom ili metastatskom okruženju osim ako ta liječenja nisu bila prikladna za bolesnike. Nastavak liječenja moguć je isključivo kod pozitivnog tumorskog odgovora na provedeno liječenje (kompletna remisija, parcijalna remisija ili stabilna bolest) uz obveznu prvu procjenu terapijskog učinka liječenja nakon 3 ciklusa liječenja. Svaka sljedeća procjena se radi nakon provedenih 3 ciklusa liječenja. Liječenje odobrava Bolničko povjerenstvo za lijekova na prijedlog internističkog onkologa ili specijalista radioterapije i onkologije.«.

Članak 2.

Ova Odluka objavljuje se u »Narodnim novinama«, a stupa na snagu 1. veljače 2022. godine.

Klasa: 025-04/22-01/02

Urbroj: 338-01-01-22-01

Zagreb, 11. siječnja 2022.

Predsjednik
Upravnog vijeća Hrvatskog zavoda
za zdravstveno osiguranje
prof. dr. sc. Drago Prgomet, dr. med. spec., v. r.

 

 

 

Izvor: https://narodne-novine.nn.hr/clanci/sluzbeni/2022_01_6_57.html